Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 19 | 2025 | 393 | 3.940 |
Why?
|
| Epigenesis, Genetic | 8 | 2025 | 274 | 3.030 |
Why?
|
| Obesity | 6 | 2025 | 1131 | 1.790 |
Why?
|
| Mental Health | 3 | 2025 | 363 | 1.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 744 | 1.160 |
Why?
|
| Social Support | 2 | 2025 | 438 | 0.890 |
Why?
|
| Monocytes | 3 | 2022 | 275 | 0.880 |
Why?
|
| Hawaii | 8 | 2025 | 2004 | 0.860 |
Why?
|
| Biomedical Research | 3 | 2024 | 467 | 0.830 |
Why?
|
| HMGB1 Protein | 1 | 2024 | 30 | 0.830 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2024 | 81 | 0.830 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2025 | 188 | 0.820 |
Why?
|
| Behavior, Animal | 2 | 2025 | 369 | 0.800 |
Why?
|
| MicroRNAs | 3 | 2024 | 501 | 0.750 |
Why?
|
| Life Style | 1 | 2024 | 326 | 0.750 |
Why?
|
| Social Class | 1 | 2024 | 286 | 0.740 |
Why?
|
| Humans | 37 | 2025 | 42163 | 0.710 |
Why?
|
| Immunity | 1 | 2021 | 60 | 0.700 |
Why?
|
| Depression | 2 | 2025 | 837 | 0.690 |
Why?
|
| Cytokines | 1 | 2024 | 661 | 0.650 |
Why?
|
| Genetic Markers | 1 | 2019 | 146 | 0.600 |
Why?
|
| Health Status Disparities | 2 | 2024 | 705 | 0.590 |
Why?
|
| Cytosine | 2 | 2016 | 33 | 0.580 |
Why?
|
| Insulin Resistance | 1 | 2019 | 199 | 0.530 |
Why?
|
| Central Nervous System | 1 | 2016 | 150 | 0.470 |
Why?
|
| Diet | 1 | 2021 | 810 | 0.470 |
Why?
|
| Semiconductors | 1 | 2015 | 10 | 0.460 |
Why?
|
| Male | 15 | 2025 | 22779 | 0.440 |
Why?
|
| Genome | 2 | 2015 | 149 | 0.440 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 508 | 0.440 |
Why?
|
| Brain | 3 | 2025 | 1452 | 0.440 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2013 | 8 | 0.420 |
Why?
|
| HIV Infections | 2 | 2019 | 2535 | 0.410 |
Why?
|
| CpG Islands | 7 | 2024 | 107 | 0.410 |
Why?
|
| Middle Aged | 9 | 2025 | 11819 | 0.400 |
Why?
|
| Exons | 1 | 2013 | 91 | 0.400 |
Why?
|
| Female | 13 | 2025 | 24018 | 0.400 |
Why?
|
| Alternative Splicing | 1 | 2013 | 92 | 0.400 |
Why?
|
| Cohort Studies | 4 | 2025 | 1729 | 0.390 |
Why?
|
| Genome-Wide Association Study | 5 | 2024 | 421 | 0.380 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 534 | 0.350 |
Why?
|
| Conserved Sequence | 2 | 2010 | 121 | 0.340 |
Why?
|
| Genome, Human | 2 | 2013 | 143 | 0.340 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2010 | 12 | 0.340 |
Why?
|
| Pilot Projects | 2 | 2024 | 733 | 0.330 |
Why?
|
| Histones | 4 | 2013 | 194 | 0.330 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 1066 | 0.300 |
Why?
|
| Animals | 13 | 2025 | 16695 | 0.290 |
Why?
|
| Inflammation | 2 | 2024 | 729 | 0.280 |
Why?
|
| Aged | 5 | 2025 | 7982 | 0.270 |
Why?
|
| Adult | 7 | 2025 | 13458 | 0.260 |
Why?
|
| Adolescent | 5 | 2025 | 5950 | 0.260 |
Why?
|
| Mice | 10 | 2025 | 6490 | 0.240 |
Why?
|
| Lateral Ventricles | 1 | 2025 | 11 | 0.230 |
Why?
|
| Entamoeba histolytica | 1 | 2024 | 5 | 0.220 |
Why?
|
| Genome, Protozoan | 1 | 2024 | 13 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 1554 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 1804 | 0.220 |
Why?
|
| Neural Pathways | 1 | 2025 | 139 | 0.220 |
Why?
|
| Organ Specificity | 3 | 2016 | 141 | 0.220 |
Why?
|
| HCT116 Cells | 2 | 2015 | 40 | 0.220 |
Why?
|
| Child, Preschool | 3 | 2024 | 1516 | 0.220 |
Why?
|
| Employment | 1 | 2025 | 83 | 0.210 |
Why?
|
| Self Concept | 1 | 2025 | 170 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 3 | 2018 | 382 | 0.200 |
Why?
|
| Food | 1 | 2023 | 102 | 0.190 |
Why?
|
| Pregnancy | 2 | 2025 | 1737 | 0.190 |
Why?
|
| Food Supply | 1 | 2023 | 120 | 0.190 |
Why?
|
| Prospective Studies | 3 | 2024 | 1574 | 0.190 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 8 | 0.180 |
Why?
|
| Vaccines | 1 | 2022 | 64 | 0.180 |
Why?
|
| Dietary Fiber | 1 | 2021 | 50 | 0.180 |
Why?
|
| Cell Line | 4 | 2013 | 1416 | 0.180 |
Why?
|
| Simvastatin | 1 | 2021 | 29 | 0.180 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 37 | 0.170 |
Why?
|
| Disease Progression | 1 | 2024 | 661 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 246 | 0.170 |
Why?
|
| Lyases | 1 | 2021 | 45 | 0.170 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 1221 | 0.170 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1020 | 0.170 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 138 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 727 | 0.160 |
Why?
|
| Neuroglia | 1 | 2020 | 131 | 0.160 |
Why?
|
| Selenoproteins | 1 | 2021 | 146 | 0.150 |
Why?
|
| Young Adult | 3 | 2025 | 4936 | 0.150 |
Why?
|
| Aging | 1 | 2024 | 764 | 0.150 |
Why?
|
| Gene Silencing | 3 | 2010 | 154 | 0.150 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 308 | 0.150 |
Why?
|
| Diet, Gluten-Free | 1 | 2018 | 3 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 143 | 0.140 |
Why?
|
| Parkinson Disease | 1 | 2020 | 207 | 0.140 |
Why?
|
| Liver | 1 | 2021 | 503 | 0.140 |
Why?
|
| Child | 2 | 2024 | 3381 | 0.140 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 156 | 0.140 |
Why?
|
| Triglycerides | 1 | 2018 | 146 | 0.140 |
Why?
|
| Oligodendroglioma | 2 | 2008 | 6 | 0.130 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 6 | 0.130 |
Why?
|
| Mutation | 2 | 2024 | 1169 | 0.120 |
Why?
|
| Logistic Models | 1 | 2019 | 1001 | 0.120 |
Why?
|
| HIV | 1 | 2016 | 100 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1266 | 0.120 |
Why?
|
| Carrier Proteins | 2 | 2010 | 318 | 0.120 |
Why?
|
| Chromatin | 3 | 2013 | 179 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 107 | 0.120 |
Why?
|
| DNA Replication | 2 | 2013 | 153 | 0.120 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 72 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2011 | 310 | 0.120 |
Why?
|
| Brain Neoplasms | 2 | 2008 | 129 | 0.120 |
Why?
|
| RNA Splicing | 1 | 2015 | 42 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 860 | 0.110 |
Why?
|
| Self Care | 1 | 2015 | 173 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2013 | 348 | 0.110 |
Why?
|
| Histone Demethylases | 1 | 2013 | 8 | 0.100 |
Why?
|
| Nucleosomes | 1 | 2013 | 31 | 0.100 |
Why?
|
| Phenotype | 2 | 2018 | 774 | 0.100 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 336 | 0.090 |
Why?
|
| Smoking | 1 | 2018 | 1019 | 0.090 |
Why?
|
| DNA Helicases | 1 | 2011 | 46 | 0.090 |
Why?
|
| DNA, Intergenic | 1 | 2010 | 11 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 2010 | 58 | 0.080 |
Why?
|
| Reference Values | 1 | 2010 | 207 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2021 | 1010 | 0.080 |
Why?
|
| Japan | 2 | 2021 | 348 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2010 | 83 | 0.080 |
Why?
|
| Environment | 1 | 2010 | 148 | 0.080 |
Why?
|
| Nicotine | 2 | 2024 | 290 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2008 | 69 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 599 | 0.070 |
Why?
|
| Cadherins | 1 | 2007 | 102 | 0.060 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2005 | 15 | 0.060 |
Why?
|
| Astrocytoma | 1 | 2005 | 16 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2025 | 18 | 0.060 |
Why?
|
| Cation Transport Proteins | 1 | 2005 | 34 | 0.060 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2025 | 27 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 61 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 113 | 0.060 |
Why?
|
| Receptors, Peptide | 1 | 2024 | 24 | 0.050 |
Why?
|
| Virulence | 1 | 2024 | 238 | 0.050 |
Why?
|
| Virulence Factors | 1 | 2024 | 119 | 0.050 |
Why?
|
| Gene Expression | 2 | 2008 | 692 | 0.050 |
Why?
|
| Camptothecin | 1 | 2003 | 24 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 88 | 0.050 |
Why?
|
| Protozoan Proteins | 1 | 2024 | 196 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2022 | 23 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2002 | 30 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 74 | 0.050 |
Why?
|
| Pregnancy Trimesters | 1 | 2021 | 15 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2024 | 429 | 0.040 |
Why?
|
| Philippines | 1 | 2021 | 80 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2021 | 42 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2003 | 134 | 0.040 |
Why?
|
| Nucleus Accumbens | 1 | 2022 | 99 | 0.040 |
Why?
|
| Creatinine | 1 | 2021 | 102 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2021 | 100 | 0.040 |
Why?
|
| Neurons | 1 | 2008 | 1246 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 134 | 0.040 |
Why?
|
| United States | 2 | 2022 | 5072 | 0.040 |
Why?
|
| Selenium | 1 | 2021 | 150 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 253 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2022 | 960 | 0.040 |
Why?
|
| Grooming | 1 | 2018 | 5 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 577 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 1143 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2018 | 38 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 53 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2011 | 683 | 0.030 |
Why?
|
| Social Behavior | 1 | 2018 | 160 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 216 | 0.030 |
Why?
|
| Neural Tube | 1 | 2016 | 8 | 0.030 |
Why?
|
| Ectoderm | 1 | 2016 | 12 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 23 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 77 | 0.030 |
Why?
|
| Body Size | 1 | 2016 | 47 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2016 | 55 | 0.030 |
Why?
|
| Point Mutation | 1 | 2016 | 98 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 158 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 708 | 0.030 |
Why?
|
| Apoptosis | 1 | 2003 | 1541 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2021 | 990 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 2485 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2007 | 933 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2008 | 452 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 506 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 255 | 0.030 |
Why?
|
| Patient Selection | 1 | 2015 | 192 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 303 | 0.030 |
Why?
|
| RNA | 1 | 2016 | 266 | 0.030 |
Why?
|
| Community-Institutional Relations | 1 | 2015 | 208 | 0.030 |
Why?
|
| Research Design | 1 | 2015 | 370 | 0.030 |
Why?
|
| Replication Origin | 1 | 2013 | 15 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 2803 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 1068 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1586 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 30 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2013 | 36 | 0.030 |
Why?
|
| S Phase | 1 | 2013 | 37 | 0.030 |
Why?
|
| Genes, rRNA | 1 | 2013 | 14 | 0.020 |
Why?
|
| Methylation | 1 | 2013 | 118 | 0.020 |
Why?
|
| RNA, Transfer | 1 | 2013 | 29 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 44 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 63 | 0.020 |
Why?
|
| Methyltransferases | 1 | 2013 | 66 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 649 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 557 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 711 | 0.020 |
Why?
|
| Telomere | 1 | 2013 | 59 | 0.020 |
Why?
|
| Public Health | 1 | 2015 | 405 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2011 | 68 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2016 | 722 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2007 | 2598 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 458 | 0.020 |
Why?
|
| Genomics | 1 | 2011 | 289 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 94 | 0.020 |
Why?
|
| Transfection | 1 | 2008 | 526 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2007 | 90 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2007 | 206 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 534 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2005 | 7 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 454 | 0.010 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2005 | 11 | 0.010 |
Why?
|
| Retroviridae | 1 | 2005 | 25 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2005 | 72 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2005 | 50 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 997 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 633 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 165 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1559 | 0.010 |
Why?
|
| Androstadienes | 1 | 2003 | 19 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 658 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 189 | 0.010 |
Why?
|
| Computers | 1 | 2002 | 35 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 411 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 457 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2003 | 290 | 0.010 |
Why?
|
| Software | 1 | 2002 | 234 | 0.010 |
Why?
|
| Computational Biology | 1 | 2002 | 324 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1265 | 0.010 |
Why?
|